Image alt tag

Error!

X

There was a problem contacting the server. Please try after sometime.

Sorry, we are unable to process your request.

Error!

X

We're sorry, but the Insights and Intelligence Tool is temporarily unavailable

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Error!

X

We're sorry, but the Literature Center checkout function is temporarily unavailable.

If this problem persists, or if you need immediate assistance, please contact Customer Service at 1-888-522-2388.

Tracked Funds

You have 0 funds on your mutual fund watch list.

Begin by selecting funds to create a personalized watch list.

(as of 12/05/2015)

Pending Orders

You have 0 items in your cart.

Subscribe and order forms, fact sheets, presentations, and other documents that can help advisers grow their business.

A verification Email Has Been Sent

Close

An email verification email has been sent to .
Follow the instructions to complete the email validation process.

I have not received my verification email

Check your SPAM mailbox and make sure that twelcome@lordabbett.com is allowed to send you mail.

I'm still having trouble

If you're still having trouble verifying your email address. feel free to contact us.

1-888-522-2388
clientservices@lordabbett.com


OK

We're sorry. We found no record of the email address you provided.

Close

Register For a LordAbbett.com Account
Using Your Email Address.

  • Registered Financial Advisors gain access to:
  • Our data mining tool, Insight & Intelligence
  • Best in-class practice management content
  • Educational events, videos and podcasts.
  • The Lord Abbett Review - Subscribe now!

Registered but Having Problems?

If you believe you are registered and are having problems verifying your email address, feel free to contact us.

1-888-522-2388 clientservices@lordabbett.com

Terms & Condition

X

These Terms of Use ("Terms of Use") are made between the undersigned user ("you") and Lord, Abbett & Co. ("we" or "us"). They become effective on the date that you electronically execute these Terms of Use ("Effective Date").

A. You are a successful financial consultant that markets securities, including the Lord Abbett Family of Funds;

B. We have developed the Lord Abbett Intelligence System (the "Intelligence System"), a state of the art information resource that we make available to a limited community of broker/dealers through the Internet at a secure Web site (the "LAIS Site"); and

C. We wish to provide access to the Intelligence System to you as an information tool responsive to the demands of your successful business pursuant to these Terms of Use. Accordingly, you and we, intending to be legally bound, hereby agree as follows:]

1. Overview. · Scope. These Terms of Use (which we may amend from time to time) govern your use of the Intelligence System. · Revisions; Changes. We may amend these Terms of Use at any time by posting amended Terms of Use ("Amended Terms of Use") on the LAIS Site. Any Amended Terms of Use will become effective immediately upon posting. Your use of the Intelligence System after any Amended Terms of Use become effective will be deemed to constitute your acceptance of those Amended Terms of Use.We may modify or discontinue the Intelligence System at any time, temporarily or permanently, with or without notice to you. Purpose of the Intelligence System. The Intelligence System is intended to be an information resource that you may use to contribute to your business research. The Intelligence System is for broker/dealer use only; it is not to be used with the public in oral, written or electronic form. The information on the Intelligence System and LAIS Site is for your information only and is neither the tax, legal or investment advice of Lord Abbett or its third-party sources nor their recommendation to purchase or sell any security.

2. Your Privileges. · Personal Use. Your use of the Intelligence System is a nontransferable privilege granted by us to you and that we may deny, suspend or revoke at any time, with or without cause or notice. · Access to and Use of the Intelligence System. The User ID and password (together, an "Access ID") issued by us to you (as subsequently changed by you from time to time) is for your exclusive access to and use of the Intelligence System. You will: (a) be responsible for the security and use of your Access ID, (b) not disclose your Access ID to anyone and (c) not permit anyone to use your Access ID. Any access or use of the Intelligence System through the use of your Access ID will be deemed to be your actions, for which you will be responsible. · Required Technology. You must provide, at your own cost and expense, the equipment and services necessary to access and use the Intelligence System. At any time, we may change the supporting technology and services necessary to use the Intelligence System. · Availability. We make no guarantee that you will be able to access the Intelligence System at any given time or that your access will be uninterrupted, error-free or free from unauthorized security breaches.

3. Rights in Data. Our use of information collected from you will be in accordance with our Privacy Policy posted on the LAIS Site. Our compliance with our Privacy Policy will survive any termination of these Terms of Use or of your use of the Intelligence System.

4. Your Conduct in the Use of the Intelligence System. You may access, search, view and store a personal copy of the information contained on the LAIS Site for your use as a broker/dealer. Any other use by you of the Intelligence System and the information contained on the LAIS Site these Terms of Use is strictly prohibited. Without limiting the preceding sentence, you will not: · Engage in or permit any reproduction, copying, translation, modification, adaptation, creation of derivative works from, distribution, transmission, transfer, republication, compilation or decompilation, reverse engineering, display, removal or deletion of the Intelligence System, any portion thereof, or any data, content or information provided by us or any of our third-party sources in any form, media or technology now existing or hereafter developed, that is not specifically authorized under these Terms of Use.

· Remove, obscure or alter any notice, disclaimer or other disclosure affixed to or contained within the Intelligence System, including any copyright notice, trademark and other proprietary rights notices and any legal notices regarding the data, content or information provided through the Intelligence System.

· Create a hyperlink to, frame or use framing techniques to enclose any information found anywhere on the LAIS Site without our express prior written consent.

· Impersonate any person, or falsely state or otherwise misrepresent his or her affiliation with any person in connection with any use of the Intelligence System.

· Breach or attempt to breach the security of the Intelligence System or any network, servers, data, or computers or other hardware relating to or used in connection with the Intelligence System; nor (b) use or distribute through the Intelligence System software or other tools or devices designed to interfere with or compromise the privacy, security or use of the Intelligence System by others or the operations or assets of any person.

· Violate any applicable law, including, without limitation, any state federal securities laws. 5. Your Representations and Warranties. You hereby represent and warrant to us, for our benefit, as of the time of these Terms of Use and for so long as you continue to use the Intelligence System, that (a) you are, and will continue to be, in compliance with these Terms of Use and any applicable laws and (b) you are authorized to provide to us the information we collect, as described in our Privacy Policy.

6. Disclaimer of Warranties.

· General Disclaimers.

THE INTELLIGENCE SYSTEM, THE LAIS SITE AND ALL DATA, INFORMATION AND CONTENT ON THE LAIS SITE ARE PROVIDED "AS IS" AND “AS AVAILABLE” AND WITHOUT ANY REPRESENTATIONS OR WARRANTIES OF ANY KIND. WITHOUT LIMITING THE PRECEDING SENTENCE, LORD ABBETT, ITS AFFILIATES, AGENTS, THIRD-PARTY SUPPLIERS AND LICENSORS, AND THEIR RESPECTIVE EMPLOYEES, CONTRACTORS, DIRECTORS, OFFICERS AND SHAREHOLDERS (COLLECTIVELY, THE “LORD ABBETT GROUP”) EXPRESSLY DISCLAIM ALL WARRANTIES, WHETHER EXPRESS, IMPLIED OR STATUTORY, INCLUDING THE WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, TITLE, AND NONINFRINGEMENT. YOU EXPRESSLY AGREE THAT YOUR USE OF THE LAIS SITE, THE INTELLIGENCE SYSTEM, AND THE DATA, INFORMATION AND CONTENT PRESENTED THERE ARE AT YOUR SOLE RISK AND THAT THE LORD ABBETT GROUP WILL NOT BE RESPONSIBLE FOR ANY (A) ERRORS OR INACCURACIES IN THE DATA, CONTENT AND INFORMATION ON THE LAIS SITE AND THE INTELLIGENCE SYSTEM OR (B) ANY TERMINATION, SUSPENSION, INTERRUPTION OF SERVICES, OR DELAYS IN THE OPERATION OF THE LAIS SITE OR THE INTELLIGENCE SYSTEM.

· Disclaimer Regarding Investment Research.

THE INTELLIGENCE SYSTEM INCORPORATES DATA, CONTENT AND INFORMATION FROM VARIOUS SOURCES THAT WE BELIEVE TO BE ACCURATE AND RELIABLE. HOWEVER, THE LORD ABBETT GROUP MAKES NO CLAIMS, REPRESENTATIONS OR WARRANTIES AS TO THE ACCURACY, TIMELINESS, COMPLETENESS OR TRUTHFULNESS OF SUCH DATA, CONTENT AND INFORMATION. YOU EXPRESSLY AGREE THAT YOU ARE RESPONSIBLE FOR INDEPENDENTLY VERIFYING YOUR INVESTMENT RESEARCH PRIOR TO FORMING YOUR INVESTMENT DECISIONS OR RENDERING INVESTMENT ADVICE. THE LORD ABBETT GROUP WILL NOT BE LIABLE FOR ANY INVESTMENT DECISION MADE BY YOU OR ANY OTHER PERSON BASED UPON THE DATA, CONTENT AND INFORMATION PROVIDED THROUGH THE INTELLIGENCE SYSTEM OR ON THE LAIS SITE.

· Survival.

THIS SECTION 6 SHALL SURVIVE ANY TERMINATION OF THESE TERMS OF USE OR YOUR USE OF THE INTELLIGENCE SYSTEM..

7. Limitations on Liability.

NONE OF THE MEMBERS OF THE LORD ABBETT GROUP WILL BE LIABLE TO YOU OR ANY OTHER PERSON FOR ANY DIRECT, INDIRECT, INCIDENTAL, CONSEQUENTIAL, PUNITIVE, SPECIAL OR EXEMPLARY DAMAGES (INCLUDING LOSS OF PROFITS, LOSS OF USE, TRANSACTION LOSSES, OPPORTUNITY COSTS, LOSS OF DATA, OR INTERRUPTION OF BUSINESS) RESULTING FROM, ARISING OUT OF OR IN ANY WAY RELATING TO THE INTELLIGENCE SYSTEM, THE LAIS SITE OR YOUR USE THEREOF, EVEN IF THE LORD ABBETT GROUP HAS BEEN ADVISED OF THE POSSIBILITY OF SUCH DAMAGES. THIS SECTION 7 WILL SURVIVE ANY TERMINATION OF THESE TERMS OF USE OR YOUR USE OF THE INTELLIGENCE SYSTEM.

8. Miscellaneous Provisions.

· Governing Law. This Agreement will governed by and construed in accordance with the laws of the State of New York, without giving effect to applicable conflicts of law principles.

THE UNIFORM COMPUTER INFORMATION TRANSACTIONS ACT OR ANY VERSION THEREOF, ADOPTED BY ANY STATE, IN ANY FORM ("UCITA") WILL NOT APPLY TO THESE TERMS OF USE. TO THE EXTENT THAT UCITA IS APPLICABLE, THE PARTIES HEREBY AGREE TO OPT OUT OF THE APPLICABILITY OF UCITA PURSUANT TO THE OPT-OUT PROVISION(S) CONTAINED THEREIN.

The Intelligence System is not intended to be used by consumers, nor are the consumer protection laws of any jurisdiction intended to apply to the Intelligence System. You agree to initiate and maintain any action, suit or proceeding relating to these Terms of Use or arising out of the use of the Intelligence System exclusively in the courts, state and federal, located in or having jurisdiction over New York County, New York.

YOU HEREBY CONSENT TO THE PERSONAL JURISDICTION AND VENUE OF THE COURTS, STATE AND FEDERAL, LOCATED IN OR HAVING JURISDICTION OVER NEW YORK COUNTY, NEW YORK. YOU AGREE THAT YOU WILL NOT OBJECT TO A PROCEEDING BROUGHT IN YOUR LOCAL JURISDICTION TO ENFORCE AN ORDER OR JUDGMENT OBTAINED IN NEW YORK.

· Relationship of Parties. The parties to these Terms of Use are independent contractors and nothing in these Terms of Use will be construed as creating an employment relationship, joint venture, partnership, agency or fiduciary relationship between the parties.

· Notice. All notices provided under these Terms of Use will be in writing and will be deemed effective: (a) when delivered personally, (b) when received by electronic delivery, (c) one business day after deposit with a commercial overnight carrier specifying next day delivery, with written verification of receipt, or (d) three business days after having been sent by registered or certified mail, return receipt requested. We will only accept notices from you in English and by conventional mail addressed to: General Counsel Lord, Abbett & Co. 90 Hudson Street Jersey City, N.J. 07302-3973 We may give you notice by conventional mail or electronic mail addressed to the last mail or electronic mail address transmitted by you to us.

· Third-Party Beneficiaries. The members of the Lord Abbett Group are third-party beneficiaries of the rights and benefits provided to us under these Terms of Use. You understand and agree that any right or benefit available to us or any member of the Lord Abbett Group hereunder will also be deemed to accrue to the benefit of, and may be exercised directly by, any member of the Lord Abbett Group to the extent applicable.

· Survival. This Section 8 will survive any termination of these Terms of Use or your use of the Intelligence System. The undersigned hereby signs these Terms of Use. By electronically signing and clicking "Accept" below, these Terms of Use will be legally binding on me. To sign these Terms of Use, confirm your full name and enter your User ID and Password (as your electronic signature) in the fields indicated below and click the “I Accept” button.

Reset Your Password

Financial Professionals*

Your password must be a minimum of characters.

Confirmation Message

Your LordAbbett.com password was successully updated. This page will be refreshed after 3 seconds.

OK

 

Multi-Asset Growth Fund

Summary

Summary

What is the Multi-Asset Growth Fund?

The Fund seeks to deliver long-term growth of capital and current income by investing primarily in Lord Abbett Funds that invest in a wide variety of U.S. and international stocks along with select bonds.

DIVERSE ASSETS

The Fund is designed with the flexibility to invest in stocks, bonds, and currencies from around the world.

TACTICALLY MANAGED

The investment team can rapidly shift allocations based on market opportunities and to hedge unwanted exposures.

STRONG TOTAL RETURN

Led by a senior Investment Committee, the Fund has delivered competitive performance relative to a broad universe of multi-asset class strategies.

Yield

12-Month Dividend Yield 1 as of 02/27/2017  

  Subsidized3 Un-Subsidized4
w/o sales charge 2.69% 2.52%
w/ sales charge 2.63% 2.47%

30-Day Standardized Yield 2 as of 01/31/2017  

2.42%

Expense Ratioas of 01/31/2017

Fund Basicsas of 01/31/2017

Total Net Assets
$1.06 B
Inception Date
06/30/2005
Dividend Frequency
Quarterly
CUSIP
543916613
Minimum Initial Investment
$1,500+

Fund Expense Ratio :

1.23%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 06/30/2005
w/o sales charge 1.07% 19.17% 5.89% 8.98% 5.52% 6.45%
Lipper Category Avg. Mixed-Asset Target Alloc Growth Funds 1.69% 13.46% 5.21% 8.09% 4.67% -
Blended Index 1.72% 15.59% 7.04% 9.89% 6.01% 7.02%
w/ sales charge -1.22% 16.47% 5.09% 8.49% 5.29% 6.24%

Fund Expense Ratio :

1.23%

Fund Expense Ratio :

1.23%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 06/30/2005
w/o sales charge 12.54% 12.54% 4.72% 9.84% 5.52% 6.40%
Lipper Category Avg. Mixed-Asset Target Alloc Growth Funds 7.03% 7.04% 3.85% 8.63% 4.62% -
Blended Index 9.18% 9.18% 5.72% 10.36% 5.96% 6.92%
w/ sales charge 10.04% 10.04% 3.93% 9.34% 5.28% 6.19%

Fund Expense Ratio :

1.23%

Investment Team

martini
Giulio Martini

Director of Strategic Asset Allocation

32 Years of Industry Experience

Robert A. Lee
Robert A. Lee

Partner & Chief Investment Officer

26 Years of Industry Experience

Supported By 8 Investment Professionals and 25 Years Avg. Industry Experience

Contact a Representative

To contact your representative, enter your zip code and select your channel below.

Performance

Performance

12-Month Dividend Yield 1 as of 02/27/2017  

  Subsidized3 Un-Subsidized4
w/o sales charge 2.69% 2.52%
w/ sales charge 2.63% 2.47%

30-Day Standardized Yield 2 as of 01/31/2017  

  Subsidized5 Un-Subsidized6
w/o sales charge 2.42% 2.42%

Fund Expense Ratio :

1.23%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 06/30/2005
w/o sales charge 1.07% 19.17% 5.89% 8.98% 5.52% 6.45%
Lipper Category Avg. Mixed-Asset Target Alloc Growth Funds 1.69% 13.46% 5.21% 8.09% 4.67% -
Blended Index 1.72% 15.59% 7.04% 9.89% 6.01% 7.02%
w/ sales charge -1.22% 16.47% 5.09% 8.49% 5.29% 6.24%

Fund Expense Ratio :

1.23%

Fund Expense Ratio :

1.23%

YTD 1-YR 3-YR 5-YR 10-YR Since Inception 06/30/2005
w/o sales charge 12.54% 12.54% 4.72% 9.84% 5.52% 6.40%
Lipper Category Avg. Mixed-Asset Target Alloc Growth Funds 7.03% 7.04% 3.85% 8.63% 4.62% -
Blended Index 9.18% 9.18% 5.72% 10.36% 5.96% 6.92%
w/ sales charge 10.04% 10.04% 3.93% 9.34% 5.28% 6.19%

Fund Expense Ratio :

1.23%

Best returns

Durations Fund Returns Blended Index
3-Mo 25.92 22.23
1-Yr 51.59 45.39

Worst returns

Durations Fund Returns Blended Index
3-Mo -28.14 -25.97
1-Yr -36.21 -35.08
Year Fund Returns Blended Index
2016 12.54% 9.18%
2015 -5.02% 0.27%
2014 7.43% 7.95%
2013 20.61% 21.32%
2012 15.47% 14.21%
2011 -4.73% 1.17%
2010 14.23% 13.32%
2009 34.86% 27.39%
2008 -33.05% -30.03%
2007 8.92% 6.66%
2006 11.89% -
2005 6.57% -
Year Q1 Q2 Q3 Q4 Yearly Returns
2017 - - - - 3.57%
2016 0.63% 2.86% 4.57% 3.98% 12.54%
2015 2.41% -0.73% -8.17% 1.74% -5.02%
2014 2.80% 4.29% -2.59% 2.87% 7.43%
2013 7.65% 0.42% 4.93% 6.33% 20.61%
2012 10.51% -4.59% 5.59% 3.72% 15.47%
2011 4.41% -0.04% -16.18% 8.90% -4.73%
2010 4.58% -9.86% 11.12% 9.06% 14.23%
2009 -6.27% 18.83% 16.63% 3.82% 34.86%
2008 -7.84% -1.03% -10.55% -17.93% -33.05%
2007 2.21% 4.73% 3.76% -1.93% 8.92%
2006 4.61% -2.41% 3.86% 5.52% 11.89%
2005 - - 3.42% 3.05% 6.57%

Growth of $10,000 as of 01/31/2017

NAV Historical Prices

Date Net Asset Value

Portfolio

Portfolio

Portfolio Positioning as of 12/31/2016

  • We increased the portfolio’s exposure to U.S. and international equities over the course of the fourth quarter, as the global economic outlook continued to improve at a pace that exceeded the expectations of many investors. 
  • We added to the portfolio’s position in high yield bonds in the fourth quarter, and now maintain portfolio exposure near our equilibrium weights. High yield spreads continued to tighten throughout the quarter, which helped buffer the impact of the rise in risk-free rates that took place, as investors revised upward their expectations for future short-term rates.
  • We continue to favor short-duration and inflation-protected securities over longer duration fixed income, as we expect the U.S. Federal Reserve to continue removing stimulus as inflation continues to grind higher and the U.S. economy approaches full employment.
  • The portfolio maintained a long U.S. dollar position against developed market currencies, such as the yen, euro, British pound, and the Australian dollar, during the quarter. We expect the Fed’s ongoing tightening of monetary policy will continue benefiting the dollar, while the potential for fiscal stimulus may also propel the U.S. currency higher. Further, we continue to view the U.S. dollar as a form of cheap “insurance,” meaning that we believe the dollar should provide some cushion on the downside if global markets are confronted with an unexpected shock.
Holding Assets
High Yield Fund 22.5%
Mid Cap Stock Fund 19.5%
Calibrated Mid Cap Value Fund 18.8%
International Dividend Income Fund 18.0%
Calibrated Large Cap Value Fund 10.8%
Affiliated Fund 5.0%
International Core Equity Fund 2.4%
Inflation Focused Fund 2.0%
Short Duration Income Fund 0.8%

Equity Sector Allocation as of 01/31/2017

Rating Assets
Financials
Industrials
Energy
Information Technology
Consumer Discretionary
Real Estate
Utilities
Materials
Health Care
Consumer Staples
Telecommunication Services
Unclassified

Dividends & Cap Gains

Dividends & Cap Gains

Dividend Payments

For
YTD Dividends Paidas of 02/27/2017
$0
Dividend Frequency
Quarterly
Record Date Ex-Dividend Date Reinvest & Payable Date Dividend Reinvest Price
12/29/2016 12/30/2016 12/30/2016 $0.20290 $16.82
12/20/2016 12/21/2016 12/21/2016 $0.04020 $17.10
09/29/2016 09/30/2016 09/30/2016 $0.04890 $16.41
06/29/2016 06/30/2016 06/30/2016 $0.10010 $15.74
03/30/2016 03/31/2016 03/31/2016 $0.07710 $15.40

Upcoming Dividend Payment Dates

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date Reinvest & Payable Date
03/30/2017 03/31/2017 03/31/2017
06/29/2017 06/30/2017 06/30/2017
09/28/2017 09/29/2017 09/29/2017
12/28/2017 12/29/2017 12/29/2017

Capital Gains Distributions

For
Record Date Reinvest & Payable Date Long-term Short-term * Total Reinvest Price
12/21/2015 12/22/2015 $0.6830 $0.0634 $0.7464 $15.45

Upcoming Capital Gain Distribution

This section lists all anticipated income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.

Record Date Ex-Dividend Date
12/19/2017 12/20/2017

Fees & Expenses

Fees & Expenses

Sales Charge Schedule as of 02/27/2017

  Sales Charge Dealer's Concession Prices at Breakpoint
Less than $100,000 2.25% 2.00% $17.82
$100,000 to $249,999 1.75% 1.50% $17.73
$250,000 to $499,999 1.25% 1.00% $17.64
$500,000 to $999,999 0.00% 1.00% $17.42
$1,000,000 to $5,000,000 0.00% 1.00% $17.42

Expense Ratioas of 01/31/2017

Fund Review

Fund Review

Fund Review as of 12/31/2016

The Fund* outperformed its benchmark, a blend of 55% Russell 1000® Index1/ 20% Barclays U.S. Aggregate Bond Index2/15% MSCI EAFE Index with Gross Dividends3/10% BofA Merrill Lynch U.S. High Yield Constrained Index,4 for the quarter ended December 31, 2016.

The allocation to high yield bonds contributed to performance, as this category outperformed the Fund’s benchmark. High yield bonds continued outperforming amid rising oil prices due to agreed-upon production cuts and a general “risk-on” environment. In addition, exposure to domestic mid-cap equities helped relative performance. The prospect of higher domestic growth due to potential increases in infrastructure spending, reduced regulation, and cuts in both personal and income taxes fueled the rally in mid-cap stocks during the quarter. 

At the asset allocation level, the Fund’s holdings in emerging markets currencies detracted from relative performance, as the category underperformed the Fund’s benchmark. The unexpected outcome of the election in the United States, followed by the spike in the Treasury yields, caused emerging markets currencies to lag the returns of other asset classes during the quarter.

Please refer to www.lordabbett.com under the “Portfolio” tab for a complete list of holdings of the Fund, including the securities discussed above.

Outlook

The global scope of the current recovery likely has been fed by a supply side recovery, heralding an end to a period of widespread inventory liquidation and a pickup in both business capital spending and exports. If these trends fuel above trend economic growth in the first half of 2017, and U.S. fiscal stimulus comes into play in the second half of the year, it should result in an improvement in earnings and credit fundamentals sufficient enough to extend the rally in equities and high yield debt that began in February 2016.

U.S. and global inflation are up from their lows, as base effects from rising energy prices translate into higher year-over-year price increases. However, with continued slack in global employment rates (the U.S. and Japanese economies are among the few global economies close to full employment), there is still no sign of embedded pressure that would trigger a sharp rise in core inflation rates. This should allow central banks to continue removing monetary stimulus gradually during 2017 and for asset prices to continue toward normalization along an upward sloping path.

While we believe that 2017 is set to be another year of elevated political risk, as the new administration takes office in the United States; “Brexit” negotiations commence between the United Kingdom and the European Union; China undergoes a potential leadership transition; and elections are held in key eurozone countries - including Germany, France, and the Netherlands - these events likely will be met with equanimity by the markets, provided economic growth and inflation meet expectations.

The Fund invests principally in the underlying funds. The percentages are based on individual securities owned in one or more of the underlying funds. The Fund’s portfolio is actively managed and, therefore, its holdings and the weightings of a particular issuer or particular sector as a percentage of portfolio assets may change significantly over time. Sectors may include many industries. The mention of specific portfolio holdings is for information only. It does not constitute a recommendation or an offer for a particular security or fund, nor should it be taken as a solicitation or recommendation to buy or sell securities or other investments.

Fund Documents

Fund Documents

Download fund documents & literature, create email subscriptions, and place direct mail order

0Documents selected
Order
Summary Prospectus
Publish Date:11/03/2015
n/a
Statutory Prospectus
Publish Date:11/03/2015
n/a
Prospectus (XBRL)
Publish Date:11/03/2015
SAI
Publish Date:11/03/2015
Annual Report
Publish Date:11/03/2015
Semi-Annual Report
Publish Date:11/03/2015
Fact Sheet
Publish Date:11/03/2015
Quarterly Perspectives
Publish Date:11/03/2015

To order literature visit full website

You may add to your cart by selecting quantities in each row below.

No rows selected. Please Go back and select at least one fund document

 
Quantity
Quantity
Remove
Remove

Class A  Except as noted below, returns with sales charges reflect a maximum sales charge of 5.75% for equity funds, 2.25% for all tax-free income funds, fixed income funds and multi-asset class funds. There are also ongoing 12b-1 service fees (and, in certain cases, distribution fees).

Class A Shares purchased subject to a front-end sales charge have no contingent deferred sales charge (CDSC). However, certain purchases of Class A shares made without a front-end sales charge may be subject to a CDSC of 1% if the shares are redeemed before the first day of the month in which the one year anniversary of the purchase falls. The CDSC is not reflected in the performance with maximum sales charge.

Blended Index consists of the following components: 55% Russell 1000®  Index, 20% Barclays U.S. Aggregate Bond Index, 15% MSCI EAFE Index with Gross Dividends and 10% BofA Merrill Lynch U.S. High Yield Master II Constrained Index. Index is unmanaged, does not reflect the deduction of fees or expenses; and is not available for direct investment.  

The Russell 1000® Index measures the performance of the 1,000 largest companies in the Russell 3000 Index, which represents approximately 92% of the total market capitalization of the Russell 3000 Index.

The Barclays U.S. Aggregate Bond Index is an unmanaged index composed of securities from the Barclays Government/Corporate Bond Index, Mortgage-Backed Securities Index and the Asset-Backed Securities Index. Total return comprises price appreciation/depreciation and income as a percentage of the original investment. Indexes are rebalanced monthly by market capitalization.

The BofA Merrill Lynch U.S. High Yield Master II Constrained Index is a market value-weighted index of all domestic and Yankee high-yield bonds, including deferred interest bonds and payment–in-kind securities.  Issues included in the index have maturities of one year or more and have a credit rating lower than BB-/Baa3, but are not in default.  The index limits any individual issuer to a maximum of 2% benchmark exposure. 

Index constituents are capitalization-weighted, based on their current amount outstanding, provided the total allocation to an individual issuer does not exceed 2%. Issuers that exceed the limit are reduced to 2% and the face value of each of their bonds is adjusted on a pro-rata basis. The face values of bonds of all other issuers that fall below the 2% cap are increased on a pro-rata basis. In the event there are fewer than 50 issuers in the Index, each is equally weighted and the face values of their respective bonds are increased or decreased on a prorate basis.

 

The MSCI EAFE Index (Europe, Australasia, Far East) is a free float-adjusted market capitalization index that is designed to measure the equity market performance of developed markets, excluding the US & Canada.

The MSCI EAFE Index consists of the following 21 developed market country indices: Australia, Austria, Belgium, Denmark, Finland, France, Germany, Hong Kong, Ireland, Israel, Italy, Japan, the Netherlands, New Zealand, Norway, Portugal, Singapore, Spain, Sweden, Switzerland, and the United Kingdom. The MSCI EAFE Index with Gross Dividends approximates the maximum possible dividend reinvestment. The amount reinvested is the entire dividend distributed to individuals resident in the country of the company, but does not include tax credits. The MSCI EAFE Index with Net Dividends approximates the minimum possible dividend reinvestment. The dividend is reinvested after deduction of withholding tax, applying the rate to non-resident individuals who do not benefit from double taxation treaties. MSCI uses withholding tax rates applicable to Luxembourg holding companies, as Luxembourg applies the highest rate.

MSCI makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, reviewed or produced by MSCI.

Select funds to run a Morningstar Hypothetical Report.

    Please confirm your literature shipping address

    Please review the address information below and make any necessary changes.

    All literature orders will be shipped to the address that you enter below. This information can be edited at any time.

    Current Literature Shipping Address

    * Required field